ArticleCancers2023

Exploring the In Vitro and In Vivo Therapeutic Potential of BRAF and MEK Inhibitor Combination in NRAS-Mutated Melanoma.

Heike Niessner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.